BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2003
View Archived Issues
Argenta identifies candidate series in Pharmagene IBS collaboration
Read More
Glucocorticoid receptor antagonists as a potential alternative therapy for depression
Read More
NIAID grant supports development of RNAi approach for hepatitis B treatment
Read More
Large Scale Biology awarded HIV vaccine research grant
Read More
Positive phase IIIb results for MT-100
Read More
Potential use of MCH1 receptor antagonists in anxiety and depression
Read More
New data on ST-1535, a novel selective adenosine A2A receptor antagonist
Read More
Nemifitide well tolerated in patients with major depression
Read More
No discontinuation symptoms following treatment with agomelatine for major depression
Read More
Evidence of clinical benefits for COX-2 inhibitors in schizophrenia
Read More
Divalproex more effective than gabapentin against aggressive behavior
Read More
Reduced risk of relapse with duloxetine in major depression
Read More
Ariad scientists design new rapamycin-based immunosuppressants
Read More
Yamanouchi claims new BK(Ca) channel openers for use in urinary incontinence
Read More
Novel gamma-secretase inhibitors prepared and tested by Schering and Pharmacopeia scientists
Read More
Patient dosing begins in phase III satraplatin trial for prostate cancer
Read More
Galileo patent covers novel agents for oxidative stress-related disorders
Read More
DNA-binding free radical scavengers with potential as chemoprotective agents
Read More
Dual Tie-2/VEGFR2 inhibitors claimed by GSK researchers
Read More
Aventis enters SARS vaccine development agreement with NIAID
Read More
Orphan drug status granted for Voraxaze
Read More
FDA requests additional data on lumiracoxib
Read More
New phase III trial evaluates Humira for Crohn's disease
Read More
Approvable letter issued for Lexapro in GAD
Read More
Genentech completes Avastin BLA filing
Read More
ZymoGenetics and Serono initiate phase I trial with TACI-Ig
Read More
Telomerase-targeting vaccines in development at GemVax
Read More